Clinical Trial

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The rationale of the current research is to address the limitation of existing knowledge as it is not clear which of the two drugs (Dexamethasone or Methylprednisolone) is more effective in reduction of postoperative sequelae in patient with mandibular parasymphysis fracture. This study fills the gap by providing sound evidence on the preferred steroid option to help clinicians have more data to make decisions and improve patients' health. The result of this research will then be added to the evidence-based protocols for the treatment of parasymphysis fractures.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-09-28; most recent amendment 2026-04-02.
Status change: Not Yet Recruiting → Recruiting 2026-01-03
Trial Details
NCT Number NCT07208799
Lead Sponsor Nishtar Medical University
Conditions Mandible Fracture, Edema Face, Pain Management, Corticosteroid Injection
Enrollment 72 participants
Start Date 2026-01-03
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-06